KINSHASA, Democratic Republic of the Congo / RankWire.AI / – The Democratic Republic of the Congo health authorities began vaccinating populations against Ebola in Kisangani on Thursday, initiating a focused effort in Tshopo Province’s capital to safeguard frontline personnel. This campaign prioritizes healthcare workers, emergency response teams, and individuals with direct contact with confirmed cases as the country faces its most severe Ebola outbreak to date. Health Minister Samuel-Roger Kamba confirmed that the government dispatched an initial stock of the Ervebo vaccine under a compassionate-use protocol across eastern provinces impacted by the virus to protect essential workers and help interrupt transmission chains.
Official epidemiological data reveals that the current outbreak has affected six eastern provinces, including Ituri, North Kivu, South Kivu, Tshopo, Haut-Uele, and Bas-Uele. Statistics published by the Ministry of Public Health and Prevention indicate the nation has recorded 5,713 confirmed cases and 2,744 fatalities. The overall case fatality rate among confirmed patients is approximately 48% at present.
International health organizations, including the World Health Organization, have been supporting local medical teams through logistics, laboratory testing, and vaccine deployment efforts. Vaccine administration is being carried out under a compassionate-use framework while researchers observe its efficacy against the circulating strain in the region. As part of the response, the Democratic Republic of the Congo has launched an Ebola vaccination campaign, with health workers intensifying ring-vaccination strategies around identified infection clusters to contain the virus’s spread.
Prioritization of Ervebo Doses for Kisangani Healthcare Personnel
Operational challenges persist due to regional infrastructure limitations, ongoing security issues, and high population mobility in border districts. Cold-chain supply systems have been established in Kisangani to ensure vaccines remain at ultra-low temperatures before reaching remote health zones. Meanwhile, the Ebola vaccination initiative is underway, with civil defense and community health workers conducting educational campaigns to enhance disease surveillance and reporting.
Epidemiologists from the Africa Centres for Disease Control and Prevention are collaborating with local units to monitor adverse effects and assess immune responses among vaccinated populations. Officials stressed that early clinical detection combined with isolation measures and supportive treatment remains key to improving patient survival rates. Additional vaccine shipments are planned as distribution efforts extend into secondary health districts across the region.
Strict Infection Control Protocols Enforced at Treatment Facilities by Health Authorities
Response teams are expanding contact-tracing activities in both urban and rural areas within the eastern territory. Local health centers are receiving protective gear, diagnostic reagents, and therapeutic supplies to bolster their readiness. The government emphasizes that comprehensive public health measures will stay in place until transmission metrics show consistent decline across all affected provinces.
The authorities have called on local communities to fully cooperate with mobile vaccination teams and follow established hygiene protocols. It is anticipated that increased immunization among high-risk populations will help stabilize infection rates over upcoming weeks. Surveillance systems will continue heightened monitoring at transportation hubs and border crossings to prevent further geographical spread.